Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nicholas Ken Yoong Hee"'
Autor:
Ying-Guat Ooi, Tharsini Sarvanandan, Nicholas Ken Yoong Hee, Quan-Hziung Lim, Sharmila S. Paramasivam, Jeyakantha Ratnasingam, Shireene R. Vethakkan, Soo-Kun Lim, Lee-Ling Lim
Publikováno v:
Diabetes & Metabolism Journal, Vol 48, Iss 2, Pp 196-207 (2024)
People with type 2 diabetes mellitus have increased risk of chronic kidney disease and atherosclerotic cardiovascular disease. Improved care delivery and implementation of guideline-directed medical therapy have contributed to the declining incidence
Externí odkaz:
https://doaj.org/article/ffaa540a82f94ee8ad4244e6b3542dfe
Autor:
Nicholas Ken Yoong Hee, Quan Hziung Lim, Lee-Ling Lim, Sharmila Paramasivam, Shireene Vethakkan, Siew Pheng Chan, Jeyakantha Ratnasingam
Publikováno v:
Journal of the Endocrine Society. 6:A303-A303
Context Alpelisib is an oral phosphatidylinositol-3-kinase alpha (PI3Ka) inhibitor approved in 2019 for treatment of ER/PR+, HER2-negative advanced breast cancer. The main side effect of PI3Ka inhibition is hyperglycemia. Case A 38 year-old woman was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be9db58c430ace79de1f49b33d336aa0
https://doi.org/10.1210/jendso/bvac150.626
https://doi.org/10.1210/jendso/bvac150.626
Publikováno v:
Journal of the Endocrine Society; 2022 Supplement, Vol. 6, pA263-A430, 513p